<DOC>
	<DOCNO>NCT00525135</DOCNO>
	<brief_summary>RATIONALE : Drugs valproic acid may make thyroid cancer radioiodine sensitive , allow detection tumor make ablation treatment effective .</brief_summary>
	<brief_title>Valproic Acid ( Depakote ER ) Patients With Advanced Thyroid Cancer</brief_title>
	<detailed_description>PURPOSE : This phase II trial study well valproic acid work treat patient thyroid cancer respond well treatment .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>INCLUSION CRITERIA : DISEASE CHARACTERISTICS Diagnosis advanced/poorly differentiate thyroid cancer follicular cell origin radioiodineunresponsive Cumulative dose radioiodine &lt; 800 mCi No radioiodine uptake whole body scan within 18 month enrollment Inoperable extensive locoregional tumor mass and/or metastatic spread Failed conventional therapy include total thyroidectomy AND radioactive iodine I 131 ablation Elevated thyroglobulin level ( &gt; 2ng/ml thyroid hormone , &gt; 10ng/ml thyroid hormone ) Tgantibody positive PATIENT CHARACTERISTICS 18 year old Entry lab result : Hemoglobin &gt; 8.0 gm/dl Absolute Neutrophil Count &gt; 750 cells/mm3 Platelet count &gt; 75000/mm3 BUN &lt; 1.5 time upper limit normal ( ULN ) Creatinine &lt; 1.5 time ULN Total protein &gt; 6.4 Total bilirubin &lt; 1.5 time ULN . AST ( SGOT ) , ALT ( SGPT ) , ALKP amylase &lt; 1.5 time ULN Amylase &lt; 1.5 time ULN Albumin &gt; 2.5 Ammonia &lt; 1.5 time ULN EXCLUSION CRITERIA : Not pregnant No nursing within past 3 month No allergy valproic acid No coexist malignancy basal cell carcinoma No hepatic disease significant dysfunction Karnofsky score &gt; 80 No pancreatitis No kidney dysfunction Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>